Publications

5674 Results

Genetic polymorphisms in oxidative stress-related genes correlated with outcome following anthracycline-based therapy for aggressive B-cell non-hodgkins lymphomas

Authors
H Tardif;S Yao;B Goldman;C Spier;M LeBlanc;L Rimsza;D Persky;T Miller;RI Fisher;C Ambrosone;M Briehl
Journal / Conference
Blood 116:abst.#321; American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Analysis of CRLF2/JAK expression and mutation status in adult ALL patients

Authors
O Sala-Torra;G Pogosov;E Pogosova-Agadjanyan;H Gundacker;S Forman;S O'Donnell;F Appelbaum;C Willman;JP Radich
Journal / Conference
Blood 116:Abstract 758; American Society of Hematology Annual Meeting; oral
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0333, SWOG-9400

Over-expression of novel IRF8 splice variants is associated with a significant decrease in relapse-free survival in adult AML patients

Authors
E Porosova-Agadjanyan;K Kopecky;H Lee;J Anderson;J Godwin;A List;S Meshinchi;V Oehler;S Petersdorf;C Willman;F Appelbaum;JP Radich;D Stirewalt
Journal / Conference
Blood 116:Abstract 1679; American Society of Hematology Annual Meeting; poster
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500

A phase II study of lenalidomide for previously untreated deletion (del) 5q acute myeloid leukemia (AML) patients age 60 or older who are not candidates for remission induction chemotherapy (Southwest Oncology Group study S0605)

Authors
M Sekeres;H Gundacker;J Lancet;A Advani;S Petersdorf;J Liesveld;D Mulford;T Norwood;C Willman;A List;F Appelbaum
Journal / Conference
American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0605

R-CHOP versus (vs) CHOP followed by maintenance rituximab (MR) vs observation in older diffuse large B-cell lymphoma (DLBCL) patients (pts): long-term follow-up of Intergroup E4494/C9793

Authors
V Morrison;F Hong;T Haberman;RI Fisher;B Cheson;B Kahl;SJ Horning;B Peterson
Journal / Conference
Blood 116:Abstract 589; ASH 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
E4494

A randomized phase III trial of ABVD vs. Stanford V +/- radiation therapy in locally extensive and advanced stage hodgkin's lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

Authors
L Gordon;F Hong;RI Fisher;N Bartlett;JM Connors;R Gascoyne;H Wagner;P Stiff;B Cheson;M Gospodarowicz;R Advani;B Kahl;J Friedberg;K Blum;T Habermann;J Tuscano;R Hoppe;R Horning
Journal / Conference
Blood 116:abst.#415; American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
E2496

Phase II trial of standard dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and Rituximab (R-CHOP) plus bevacizumab for advanced stage diffuse large B-cell (DLBCL) NHL: Southwest Oncology Group study S0515

Authors
A Stopeck;J Unger;L Rimsza;B Farnsworth;M LeBlanc;M Iannone;RI Fisher;TP Miller
Journal / Conference
Blood 116:abst.#591; American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
S0515

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): Southwest Oncology Group protocol S0433

Authors
J Friedberg;J Unger;WR Burack;AK Gopal;M LeBlanc;O Press;TP Miller;RI Fisher
Journal / Conference
Blood 116:abst.#590; Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
S0433

A randomized phase II trial of dasatinib 100 mg vs. imatinib 400 mg in newly diagnosed chronic phase (CML-CP): the S0325 intergroup trial

Authors
J Radich;K Kopecky;S Kamel-Reid;W Reid;E Paietta;R Larson;M Tallman;F Appelbaum;B Druker
Journal / Conference
Blood 116:Abstract 6 (LBA-6); ASH late-breaking oral presentation
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0325

Clonal markers in relapsed acute promyelocytic leukemia (APL): clinicopathological associations and relation to all-trans retinoic acid (ATRA) treatment on intergroup phase III trial C9710

Authors
R Gallagher;B Moser;J Racevskis;X Poire;C Bloomfield;A Carroll;R Ketterling;D Ralston;E Schachter-Tokarz;D Zhou;I-M Chen;R Harvey;G Koval;D Sher;J Feusner;M Tallman;F Appelbaum;R Larson;B Powell;E Paietta;C Willman;W Stock
Journal / Conference
Blood 116:abst.#1038, 2010; American Society of Hematology Annual Mtg, poster
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
C9710